Understanding how bacteria latch onto human cells could revolutionize treatment approaches for urinary tract infections, which affect millions annually and increasingly resist standard antibiotics. The mechanical grip that allows pathogenic E. coli to colonize bladder tissue operates through previously unknown ultrafast shape-shifting dynamics that strengthen under stress. Researchers isolated and analyzed a single-domain variant of FimH, the key adhesion protein that enables uropathogenic E. coli to bind to bladder cells. This protein exhibits remarkable conformational flexibility, undergoing ultraslow structural changes that create catch bonds—molecular connections that paradoxically strengthen when pulled apart. The catch bond mechanism allows bacteria to maintain adhesion even under the mechanical stress of urine flow, explaining why UTI-causing bacteria resist natural clearance mechanisms. The team's structural analysis revealed that FimH operates through distinct conformational states, switching between binding configurations on timescales much slower than typical protein movements. This discovery challenges conventional understanding of bacterial adhesion as a simple lock-and-key interaction. Instead, the process involves dynamic molecular shape-shifting that adapts to mechanical forces. The findings open new therapeutic avenues beyond traditional antibiotics, potentially targeting the conformational flexibility itself rather than attempting to kill bacteria outright. This mechanical approach could prove especially valuable as antibiotic resistance continues to rise globally. However, translating these molecular insights into clinical interventions remains years away, requiring extensive development of compounds that can disrupt specific protein conformations without affecting beneficial bacteria or human cellular processes.